Squarepoint’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-18,816
| Closed | -$903K | – | 2609 |
|
|
2020
Q1 | $903K | Sell |
18,816
-34,714
| -65% | -$1.67M | 0.02% | 757 |
|
|
2019
Q4 | $2.51M | Buy |
+53,530
| New | +$2.51M | 0.01% | 750 |
|
|
2019
Q3 | – | Sell |
-30,880
| Closed | -$929K | – | 2704 |
|
|
2019
Q2 | $929K | Sell |
30,880
-63
| -0.2% | -$1.9K | 0.01% | 1282 |
|
|
2019
Q1 | $693K | Sell |
30,943
-6,659
| -18% | -$149K | 0.01% | 1289 |
|
|
2018
Q4 | $684K | Sell |
37,602
-15,597
| -29% | -$284K | 0.01% | 1072 |
|
|
2018
Q3 | $962K | Buy |
53,199
+37,678
| +243% | +$681K | 0.01% | 1006 |
|
|
2018
Q2 | $154K | Buy |
+15,521
| New | +$154K | ﹤0.01% | 1585 |
|
|
2018
Q1 | – | Sell |
-19,592
| Closed | -$167K | – | 2363 |
|
|
2017
Q4 | $167K | Buy |
+19,592
| New | +$167K | ﹤0.01% | 1838 |
|
|
2017
Q3 | – | Sell |
-10,500
| Closed | -$197K | – | 1986 |
|
|
2017
Q2 | $197K | Buy |
+10,500
| New | +$197K | ﹤0.01% | 1302 |
|